BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 8564191)

  • 1. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
    Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
    Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
    Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney.
    Vieira-Coelho MA; Serrão P; Guimarães JT; Pestana M; Soares-da-Silva P
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1033-44. PubMed ID: 11097621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
    Vieira-Coelho MA; Pestana M; Soares-da-Silva P
    Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
    Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.
    Armando I; Nowicki S; Aguirre J; Barontini M
    Am J Physiol; 1995 Jun; 268(6 Pt 2):F1087-92. PubMed ID: 7611449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.
    Soares-da-Silva P; Pinto-do-O PC
    Br J Pharmacol; 1996 Mar; 117(6):1187-92. PubMed ID: 8882614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats.
    Vieira-Coelho MA; Hussain T; Kansra V; Serrao MP; Guimaraes JT; Pestana M; Soares-Da-Silva P; Lokhandwala MF
    Hypertension; 1999 Oct; 34(4 Pt 1):666-72. PubMed ID: 10523344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the synthesis of dopamine in the human, dog and rat kidney.
    Soares-da-Silva P; Fernandes MH; Pestana M
    Acta Physiol Scand; 1993 Jul; 148(3):347-51. PubMed ID: 8213189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outflow of dopamine and noradrenaline originating from L-dopa and L-threo-DOPS in rat renal tissues.
    Pestana M; Soares-Da-Silva P
    Gen Pharmacol; 1994 Sep; 25(5):879-85. PubMed ID: 7835631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of tubular sodium in the formation of dopamine in the human renal cortex.
    Soares-da-Silva P; Pestana M; Fernandes MH
    J Am Soc Nephrol; 1993 Mar; 3(9):1591-9. PubMed ID: 8507815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of renal dopaminergic system activity during the recovery of renal function in human kidney transplant recipients.
    Pestana M; Faria MS; Oliveira JG; Baldaia J; Santos A; Guerra LE; Soares-da-Silva P
    Nephrol Dial Transplant; 1997 Dec; 12(12):2667-72. PubMed ID: 9430869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney.
    Sampaio-Maia B; Moreira-Rodrigues M; Pestana M
    Nephron Physiol; 2006; 103(1):p14-24. PubMed ID: 16352914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deamination of newly-formed dopamine in rat renal tissues.
    Fernandes MH; Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1991 Mar; 102(3):778-82. PubMed ID: 1364853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
    Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.